Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-03-08
2011-03-08
Kosack, Joseph R (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S125000, C546S126000
Reexamination Certificate
active
07902222
ABSTRACT:
The invention relates to biaryl substituted azabicyclic alkane derivatives, compositions comprising such compounds, and methods of treating conditions and disorders using such compounds and compositions.
REFERENCES:
patent: 2005/0043347 (2005-02-01), Betschmann et al.
patent: 2008/0045539 (2008-02-01), Ji et al.
patent: 2008/0234308 (2008-09-01), Bunnelle et al.
patent: 00/71520 (2000-11-01), None
patent: 03/062235 (2003-07-01), None
patent: 2004/037823 (2004-05-01), None
patent: 2006/101745 (2006-09-01), None
Rautio et al. Nature Reviews Drug Discovery 2008, 7, pp. 255-270.
Wang et al. Drug Delivery: Principles and Applications, 2005 John Wiley & Sons, Inc. Publication, Section 8.3, pp. 136-137.
Smith, D. A. Current Opinion in Drug Discovery & Development 2007, 10, 550-559.
Testa, B. Current Opinion in Chemical Biology 2009, 13, pp. 338-344.
Adler, E., et al., Schizophrenia Bulletin, 24(2): 189-202 (1998).
Cordero-Erausquin, M., et al., PNAS, 98(5): 2803-2807 (2001).
Friedman, J., et al., Society of Biol. Psych., 51: 349-357 (2002).
Furniss, B., et al., Vogel's Textbook of Practical Organic Chemistry, 5th edition (1989), Longman Scientific & Technical.
Greene, T.W., et al., Protecting Groups in Chemical Synthesis (3rd ed), John Wiley & Sons, NY, Table of Contents (1999).
Heeschen, C., et al., Nature Medicine, 7:833-839 (2001).
Heeschen, C., et al., J. Clin. Invest., 110:527-536 (2002).
Jonnala, R., et al., Journal of Neuroscience Research, 66: 565-572 (2001).
Kihara, T., et al., Journal of Biological Chemistry, 276: 13541-13546 (2001).
Leonard, S., et al., European Journal of Pharmacology, 393: 237-242 (2000).
Levin, E., J. Neurobiol., 53: 633-640 (2002).
Liu, Q., et al., PNAS, 98: 4734-4739 (2001).
Pabreza, L., et al., Molecular Pharmacology, 39: 9-12 (1991).
Paterson, D., et al., Progress in Neurobiology, 61: 75-111 (2000).
Prescott, D., Methods in Cell Biology, XIV: 33 et., Academic Press, New York, NY (1996).
Recommendations for Section E, Fundamental Stereochemistry, Pure and Applied Chemistry, 45:13-30 (1976).
Rollema, H., et al., Trends Pharmacological Sciences, 28(7):316-25 (2007).
Rose, J., et al., Biochem. Pharmacol., 74(8):1263-1270 (2007).
Rowley, M., et al., Journal of Medicinal Chemistry, 44(4): 477-501 (2001).
Shimohama, S., et al., Brain Research, 779: 359-363 (1988).
Solinas, M., et al., The Journal of Neuroscience, 27(21):5615-5620 (2007).
Son, J., et al., Biology of Reproduction, 68:1348-1353 (2003).
Steensland, P. et al., PNAS, 104(30): 12518-12523 (2007).
Stevens, K., Psychopharmacology, 136: 320-327 (1998).
Wang, H., et al., Nature, 421:384-388 (2003).
International Search Report dated Feb. 12, 2009.
Higuchi, T. et al., Pro-drugs as Novel Drug Delivery Systems (TOC), ACS Symposium Series vol. 14 (1975).
Wolter, M, et al., Copper-Catalyzed Coupling of Aryl Iodides with Aliphatic Alcohols, Organic Letters (2002), pp. 973-976, vol. 4(6).
Gopalakrishnan Murali
Ji Jianguo
Lee Chih-Hung
Li Tao
Sippy Kevin B.
Abbott Laboratories
Coughlin Matthew P
Holland Antonia M.
Kosack Joseph R
LandOfFree
Biaryl substituted azabicyclic alkane derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Biaryl substituted azabicyclic alkane derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biaryl substituted azabicyclic alkane derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2666117